Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109824176 | 10982417 | 6 | F | 2014 | 20160811 | 20150403 | 20160818 | EXP | US-PFIZER INC-2015114901 | PFIZER | 79.00 | YR | M | Y | 90.70000 | KG | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109824176 | 10982417 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 3X/DAY | U | J05186 | 21446 | 50 | MG | TID | |||||
| 109824176 | 10982417 | 2 | SS | LYRICA | PREGABALIN | 1 | UNK | U | L5321 | 21446 | |||||||||
| 109824176 | 10982417 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY | U | 21446 | 75 | MG | BID | ||||||
| 109824176 | 10982417 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 3X/DAY | U | M71819 | 21446 | 50 | MG | TID | |||||
| 109824176 | 10982417 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | UNK | U | 21446 | |||||||||
| 109824176 | 10982417 | 6 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | 20 MG, 2X/DAY | 0 | 20 | MG | BID | ||||||||
| 109824176 | 10982417 | 7 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | 40 MG, 1X/DAY (IN THE MORNING) | 0 | 40 | MG | QD | ||||||||
| 109824176 | 10982417 | 8 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 200 MG, DAILY | 0 | 200 | MG | TABLET | ||||||||
| 109824176 | 10982417 | 9 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 100 MG, 2X/DAY | 0 | 100 | MG | TABLET | BID | |||||||
| 109824176 | 10982417 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | TABLET | |||||||
| 109824176 | 10982417 | 11 | C | TIZANIDINE. | TIZANIDINE | 1 | 4 MG, 1X/DAY (AT BED TIME) | 0 | 4 | MG | TABLET | QD | |||||||
| 109824176 | 10982417 | 12 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 10 MG, 1X/DAY (AT BED TIME) | 0 | 10 | MG | TABLET | QD | |||||||
| 109824176 | 10982417 | 13 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 80 MG, 1X/DAY | 0 | 80 | MG | QD | ||||||||
| 109824176 | 10982417 | 14 | C | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | [HYDROCHLOROTHIAZIDE 75MG/ TRIAMTERENE 50MG], 1X/DAY MORNING | 0 | 1 | DF | TABLET | QD | |||||||
| 109824176 | 10982417 | 15 | C | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | [HYDROCHLOROTHIAZIDE 75MG/ TRIAMTERENE 50MG] | 0 | TABLET | |||||||||
| 109824176 | 10982417 | 16 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 40 MG, UNK | 0 | 40 | MG | TABLET | QD | |||||||
| 109824176 | 10982417 | 17 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | TABLET | |||||||||||
| 109824176 | 10982417 | 18 | C | AXOTAL | ASPIRINBUTALBITAL | 1 | [BUTALBITAL 50MG/ CAFFEINE 325MG/ PARACETAMOL 40MG], UNK | 0 | 1 | DF | |||||||||
| 109824176 | 10982417 | 19 | C | POTASSIUM | POTASSIUM | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 109824176 | 10982417 | 20 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | PROLONGED-RELEASE TABLET | |||||||
| 109824176 | 10982417 | 21 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | UNK | 0 | TABLET | ||||||||||
| 109824176 | 10982417 | 22 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | Topical | UNK UNK, 4X/DAY (1 % TRANSDERMAL GEL, APPLY TO AFFECTED AREAS 4 TIMES DAILY TOPICALLY) | 0 | GEL | QID | ||||||||
| 109824176 | 10982417 | 23 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 15 MG, UNK | 0 | 15 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 109824176 | 10982417 | 24 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 10 MEQ, UNK | 0 | 10 | MEQ | PROLONGED-RELEASE CAPSULE | |||||||
| 109824176 | 10982417 | 25 | C | TIZANIDINE HCL | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 4 MG, UNK | 0 | 4 | MG | TABLET | |||||||
| 109824176 | 10982417 | 26 | C | FLUOXETINE HCL | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | CAPSULE | |||||||
| 109824176 | 10982417 | 27 | C | BUTALBITAL APAP CAFFEINE | 2 | Oral | UNK (BUTALBITAL 50 MG, ACETAMINOPHEN 325 MG AND CAFFEINE 40 MG) | 0 | CAPSULE | ||||||||||
| 109824176 | 10982417 | 28 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109824176 | 10982417 | 1 | Fibromyalgia |
| 109824176 | 10982417 | 2 | Peripheral nerve injury |
| 109824176 | 10982417 | 6 | Depression |
| 109824176 | 10982417 | 7 | Prophylaxis |
| 109824176 | 10982417 | 8 | Gout |
| 109824176 | 10982417 | 11 | Sleep disorder |
| 109824176 | 10982417 | 12 | Sleep disorder |
| 109824176 | 10982417 | 13 | Blood cholesterol increased |
| 109824176 | 10982417 | 14 | Gastrooesophageal reflux disease |
| 109824176 | 10982417 | 15 | Dyspepsia |
| 109824176 | 10982417 | 16 | Gastric pH decreased |
| 109824176 | 10982417 | 17 | Antacid therapy |
| 109824176 | 10982417 | 18 | Migraine |
| 109824176 | 10982417 | 19 | Blood potassium decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109824176 | 10982417 | DS |
| 109824176 | 10982417 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109824176 | 10982417 | Abasia | |
| 109824176 | 10982417 | Activities of daily living impaired | |
| 109824176 | 10982417 | Arthralgia | |
| 109824176 | 10982417 | Bedridden | |
| 109824176 | 10982417 | Blood potassium decreased | |
| 109824176 | 10982417 | Condition aggravated | |
| 109824176 | 10982417 | Drug dependence | |
| 109824176 | 10982417 | Fibromyalgia | |
| 109824176 | 10982417 | Insomnia | |
| 109824176 | 10982417 | Memory impairment | |
| 109824176 | 10982417 | Musculoskeletal pain | |
| 109824176 | 10982417 | Pain | |
| 109824176 | 10982417 | Pain in extremity | |
| 109824176 | 10982417 | Renal impairment | |
| 109824176 | 10982417 | Weight increased | |
| 109824176 | 10982417 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109824176 | 10982417 | 4 | 2014 | 0 | ||
| 109824176 | 10982417 | 5 | 201505 | 0 | ||
| 109824176 | 10982417 | 6 | 1999 | 0 | ||
| 109824176 | 10982417 | 8 | 2000 | 0 | ||
| 109824176 | 10982417 | 12 | 2005 | 0 | ||
| 109824176 | 10982417 | 13 | 2011 | 0 | ||
| 109824176 | 10982417 | 16 | 2011 | 0 |